Open access · CC-BY
via OpenAlex
Emerging uncertainty on the anti-aging potential of metformin
Matthew Thomas Keys, Jesper Hallas, Richard A. Miller, Samy Suissa, Kaare Christensen
Ageing Research Reviews · 2025 · ▲ 20 citations
Abstract
Metformin is the most commonly prescribed glucose-lowering agent worldwide for the treatment of type II diabetes. Due to evidence of improvements in healthspan(definition) and lifespan in model organisms, and mechanistic data relevant to the telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition), it has been considered a promising candidate in the search for pharmacological interventions that may attenuate the ageing process in humans. Various epidemiological studies have been influential in generating support for this hypothesis. These include pronounced anticancer and cardioprotective benefits compared to other antidiabetic treatments, and an observation of metformin use in type II diabetes being associated with better survival than that of the general population. Here we discuss recent developments in the evidence underlying the rationale for using metformin to target ageing. We describe the methodological limitations of some of the early and most influential findings and critically assess their scientific follow-up, including replication attempts of key experimental and observational findings, and a range of clinical trials of metformin in individuals without type II diabetes. These developments generally illustrate an emerging uncertainty in the anti-aging potential of metformin.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.arr.2025.102817
- Canonical
- link ↗
- Fetched
- 2026-09-19 MST
Cite this
APA
Keys, M.T., Hallas, J., Miller, R.A., Suissa, S., & Christensen, K. (2025). Emerging uncertainty on the anti-aging potential of metformin. <em>Ageing Research Reviews</em>. https://doi.org/10.1016/j.arr.2025.102817
Vancouver
Keys MT, Hallas J, Miller RA, Suissa S, Christensen K. Emerging uncertainty on the anti-aging potential of metformin. Ageing Research Reviews. 2025. doi:10.1016/j.arr.2025.102817.
BibTeX
@article{matthew2025Emergi,
title = {Emerging uncertainty on the anti-aging potential of metformin},
author = {Matthew Thomas Keys and Jesper Hallas and Richard A. Miller and Samy Suissa and Kaare Christensen},
journal = {Ageing Research Reviews},
year = {2025},
doi = {10.1016/j.arr.2025.102817},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Education Health and Sport 2025
Open access · CC-BY
Metformin - An Antidiabetic Drug With Anti-aging, Cardioprotective And Potential Anti-cancer Properties
Frontiers in Endocrinology 2021
Open access · CC-BY
A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 2013
Preprint
Faculty Opinions recommendation of Metformin improves healthspan and lifespan in mice.
Nature 2003
Open access · OA
Drinking your health? It's too early to say
BMC Public Health 2023
Open access · CC-BY
Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls
Frontiers in Immunology 2018
Open access · CC-BY